Generated by GPT-5-mini| Louis-Jeantet Prize for Medicine | |
|---|---|
![]() JBchrch · CC BY-SA 4.0 · source | |
| Name | Louis-Jeantet Prize for Medicine |
| Awarded for | Outstanding contributions to biomedical research |
| Presenter | Louis-Jeantet Foundation |
| Country | Switzerland |
| Year | 1986 |
Louis-Jeantet Prize for Medicine The Louis-Jeantet Prize for Medicine is a major Swiss biomedical award established by the Louis-Jeantet Foundation and administered through institutions including the University of Geneva and the Swiss National Science Foundation, recognizing leading scientists in fields such as molecular biology, cell biology, immunology, and neuroscience. The prize has been associated with laureates who also received distinctions like the Nobel Prize in Physiology or Medicine, the Lasker Award, and the Breakthrough Prize in Life Sciences, and its recipients have worked at organizations such as the Max Planck Society, the Francis Crick Institute, the Howard Hughes Medical Institute, and the École Polytechnique Fédérale de Lausanne.
The prize was created through the testamentary provisions of Swiss businessman and philanthropist Jules-Louis Jeantet via the Louis-Jeantet Foundation in the 1980s, drawing upon precedents set by European prizes such as the Crafoord Prize, the Wolf Prize, and the Gairdner Foundation International Award. Early awards highlighted research centers in Paris, Geneva, and Cambridge, involving laboratories at the Pasteur Institute, the University of Oxford, and the Imperial College London, and reflected broader trends seen in prizes like the Shaw Prize and the Keio Medical Science Prize. Over decades the prize adapted selection practices influenced by academies and societies including the Swiss Academy of Medical Sciences, the Royal Society, and the Academy of Medical Sciences (UK).
Candidates are typically senior and mid-career researchers working in Europe or Switzerland and affiliated with universities or institutes such as the University of Cambridge, the Karolinska Institutet, the Max Delbrück Center for Molecular Medicine, or the University of Zurich. Nominations are submitted by peers from institutions like the European Molecular Biology Laboratory, the Cold Spring Harbor Laboratory, and the Wellcome Trust, and selection involves committees composed of members drawn from organizations such as the European Research Council, the Swiss National Science Foundation, and panels with representatives from the Institut Pasteur and the European Molecular Biology Organization. The evaluation process assesses scientific achievements comparable to those recognized by the Nobel Committee for Physiology or Medicine, the Royal Swedish Academy of Sciences, and panels for awards like the Albert Lasker Medical Research Award.
The Louis-Jeantet Prize awards substantial research grants and personal prizes funded by the endowment of the Louis-Jeantet Foundation and managed through financial arrangements linked to Swiss banking institutions and philanthropic models similar to those of the Wellcome Trust and the Gordon and Betty Moore Foundation. Monetary components support laboratories at host institutions such as the University of Geneva, the Université de Genève Faculty of Medicine, the Ecole Polytechnique Fédérale de Lausanne, and research groups affiliated with the European Molecular Biology Laboratory and the Howard Hughes Medical Institute. The prize has both an annual cash award and project-directed funding, echoing mechanisms used by the Human Frontier Science Program and the European Research Council to promote translational projects and collaborations with centers like the Max Planck Institute for Biochemistry and the Johns Hopkins University School of Medicine.
Laureates have included researchers later honored by the Nobel Prize in Physiology or Medicine, the Lasker-DeBakey Clinical Medical Research Award, and the Breakthrough Prize in Life Sciences, with individuals who worked at institutions such as the Massachusetts Institute of Technology, the Stanford University School of Medicine, the University of California, San Francisco, and the Karolinska Institutet. Recipients have advanced fields linked to discoveries by figures associated with the Human Genome Project, the CRISPR-Cas9 revolution led by scientists connected to labs like those at the University of California, Berkeley and the Broad Institute, and immunology breakthroughs paralleling work at the Dana-Farber Cancer Institute and the Institut Pasteur. The award has stimulated collaborations with biotech companies and translational efforts at organizations such as Genentech, Novartis, and Roche, and its laureates have contributed to major research networks including the European Molecular Biology Organization and the International Agency for Research on Cancer.
The Louis-Jeantet Foundation, headquartered in Geneva and cooperating with the University of Geneva and agencies such as the Swiss National Science Foundation, oversees the prize administration, with advisory input from panels linked to the European Molecular Biology Laboratory, the Wellcome Trust, and the Royal Society. Day-to-day operations involve offices that liaise with academic departments at the University of Lausanne, the École Polytechnique Fédérale de Lausanne, and international partners including the Max Planck Society and the Francis Crick Institute. Governance follows nonprofit practices similar to those of the Carnegie Corporation of New York and the Bill & Melinda Gates Foundation, and award ceremonies are held in venues associated with the University of Geneva and cultural institutions in Geneva and Lausanne.
Category:Biomedical awards Category:Swiss awards